Zhejiang Xianju Pharmaceutical Co., Ltd. (SHE:002332)
China · Delayed Price · Currency is CNY 8.47
+0.08 (0.95%)
Jul 29, 2026, 3:04 PM CST
SHE:002332 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 3,669 | 3,759 | 4,001 | 4,123 | 4,380 | 4,357 |
Revenue Growth | -7.60% | -6.04% | -2.98% | -5.85% | 0.52% | 8.42% |
Gross Profit Gross Profit Growth | 2,250 | 2,262 | 2,256 | 2,152 | 2,515 | 2,509 |
Operating Income Operating Income Growth | 380.35 | 428.98 | 617.42 | 604.79 | 678.81 | 672.92 |
Net Income Net Income Growth | 399.54 | 449.64 | 397.18 | 563.08 | 749.41 | 619.33 |
Earnings Per Share EPS Growth | 0.40 | 0.45 | 0.40 | 0.57 | 0.76 | 0.63 |
EPS Growth | 1.78% | 12.50% | -29.83% | -24.76% | 21.00% | 13.84% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
China China Growth | 2,690 | 2,964 | 2,945 | 3,238 | 3,190 |
Overseas Overseas Growth | 1,069 | 1,037 | 1,179 | 1,142 | 1,167 |
Total Total Growth | 3,759 | 4,001 | 4,123 | 4,380 | 4,357 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 1,216 | 1,196 | 1,382 | 1,660 | 1,720 | 1,768 |
Total Debt Total Debt Growth | 148.43 | 201.41 | 58.95 | 219.36 | 344.42 | 739.25 |
Net Cash (Debt) Net Cash Growth | 1,068 | 994.64 | 1,323 | 1,441 | 1,376 | 1,028 |
Net Cash Growth | -17.84% | -24.82% | -8.17% | 4.70% | 33.81% | 35.35% |
Net Cash Per Share Net Cash Per Share Growth | 1.07 | 1.00 | 1.33 | 1.46 | 1.39 | 1.04 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 363.84 | 247.48 | 398.66 | 595.48 | 609.28 | 657.9 |
Capital Expenditures CapEx Growth | -182.6 | -209.07 | -207.59 | -234.63 | -282.54 | -248.58 |
Free Cash Flow Free Cash Flow Growth | 181.24 | 38.4 | 191.07 | 360.85 | 326.74 | 409.31 |
Free Cash Flow Growth | 156.73% | -79.90% | -47.05% | 10.44% | -20.17% | -39.01% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 61.32% | 60.18% | 56.40% | 52.18% | 57.42% | 57.58% |
Operating Margin | 10.37% | 11.41% | 15.43% | 14.67% | 15.50% | 15.44% |
Pretax Margin | 13.25% | 14.26% | 12.46% | 15.56% | 19.91% | 16.75% |
Profit Margin | 10.89% | 11.96% | 9.93% | 13.66% | 17.11% | 14.21% |
FCF Margin | 4.94% | 1.02% | 4.78% | 8.75% | 7.46% | 9.39% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.400 | 0.300 | 0.300 | 0.300 | 0.300 | 0.150 |
Dividend Per Share Growth | 0% | 0% | 0% | 0% | 100.00% | 0% |
Dividend Yield | 4.77% | 3.41% | 3.23% | 2.57% | 2.97% | 1.29% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 21.18 | 19.82 | 24.76 | 22.43 | 14.92 | 21.08 |
Forward PE | 17.83 | 14.65 | 12.86 | 17.64 | 14.26 | 16.42 |
P/FCF Ratio | 46.23 | 232.08 | 51.46 | 35.01 | 34.21 | 31.90 |
PS Ratio | 2.28 | 2.37 | 2.46 | 3.06 | 2.55 | 3.00 |